Gut Microbiome Critically Impacts PCB-induced Changes in Metabolic Fingerprints and the Hepatic Transcriptome in Mice
Open Access
- 1 September 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 177 (1) , 168-187
Abstract
Polychlorinated biphenyls (PCBs) are ubiquitously detected and have been linked to metabolic diseases. Gut microbiome is recognized as a critical regulator of disease susceptibility; however, little is known how PCBs and gut microbiome interact to modulate hepatic xenobiotic and intermediary metabolism. We hypothesized the gut microbiome regulates PCB-mediated changes in the metabolic fingerprints and hepatic transcriptome. Ninety-day-old female conventional and germ-free mice were orally exposed to the Fox River Mixture (synthetic PCB mixture, 6 or 30 mg/kg) or corn oil (vehicle control, 10 ml/kg), once daily for 3 consecutive days. RNA-seq was conducted in liver, and endogenous metabolites were measured in liver and serum by LC-MS. Prototypical target genes of aryl hydrocarbon receptor, pregnane X receptor, and constitutive androstane receptor were more readily upregulated by PCBs in conventional conditions, indicating PCBs, to the hepatic transcriptome, act partly through the gut microbiome. In a gut microbiome-dependent manner, xenobiotic, and steroid metabolism pathways were upregulated, whereas response to misfolded proteins-related pathways was downregulated by PCBs. At the high PCB dose, NADP, and arginine appear to interact with drug-metabolizing enzymes (ie, Cyp1–3 family), which are highly correlated with Ruminiclostridium and Roseburia, providing a novel explanation of gut-liver interaction from PCB-exposure. Utilizing the Library of Integrated Network-based Cellular Signatures L1000 database, therapeutics targeting anti-inflammatory and endoplasmic reticulum stress pathways are predicted to be remedies that can mitigate PCB toxicity. Our findings demonstrate that habitation of the gut microbiota drives PCB-mediated hepatic responses. Our study adds knowledge of physiological response differences from PCB exposure and considerations for further investigations for gut microbiome-dependent therapeutics.Keywords
Funding Information
- National Institutes of Health (R01 ES025708, R01 ES030197, R01 GM111381, R01 ES031098, T32 ES007032, ES013661, ES005605)
- University of Washington Center for Exposures, Diseases, Genomics, and Environment (NIH P30 ES0007033)
This publication has 155 references indexed in Scilit:
- phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census DataPLOS ONE, 2013
- Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencingNature Methods, 2013
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and CufflinksNature Protocols, 2012
- Nilotinib: A Novel, Selective Tyrosine Kinase InhibitorSeminars in Oncology, 2011
- Bile Acid Metabolism and the Pathogenesis of Type 2 DiabetesCurrent Diabetes Reports, 2011
- Discriminative stimulus effects of cocaine and amphetamine in rats following developmental exposure to polychlorinated biphenyls (PCBs)Neurotoxicology and Teratology, 2011
- Clearance of Polychlorinated Biphenyl Atropisomers is Enantioselective in Female C57Bl/6 MiceEnvironmental Science & Technology, 2009
- Influence of dietary fat on the enantioselective disposition of 2,2′,3,3′,6,6′-hexachlorobiphenyl (PCB 136) in female miceFood and Chemical Toxicology, 2008
- Small-molecule synergist of the Wnt/β-catenin signaling pathwayProceedings of the National Academy of Sciences, 2007
- An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative StressMolecular Cell, 2003